A Trial of AN0025 With Chemoradiation Therapy in Stage III NSCLC Participants
Rutgers, The State University of New Jersey
Rutgers, The State University of New Jersey
Roswell Park Cancer Institute
Sichuan Baili Pharmaceutical Co., Ltd.
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
New York State Psychiatric Institute
Henry Ford Health System
University of Colorado, Denver
Amgen
SWOG Cancer Research Network
Northwestern University
M.D. Anderson Cancer Center
Cancer Trials Ireland
University of Miami
VA Office of Research and Development
University of Arkansas
University of Alabama at Birmingham
University of California, San Francisco
Barbara Ann Karmanos Cancer Institute